Compare Stryker Corporation (SYK) vs Veeva Systems (VEEV) Price & Performance

Stryker CorporationTrade

Veeva SystemsTrade

Price performance (Past 24H)

Key statistics

Stryker Corporation vs Veeva Systems — how do they compare? Stryker Corporation trades at $278.6 (market cap $106.24B), while Veeva Systems trades at $290.16 (market cap $46.12B). The key difference: Stryker Corporation is far larger — about 2.3× Veeva Systems's market cap, and Stryker Corporation pays a 1.27% dividend while Veeva Systems pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 20 Days and Veeva Systems for 5 Days on average.

	SYK	VEEV
Market Cap	$106.24B	$46.12B
Volume	2,982,001	921,537
Sector	Health	Technology
52-Week High	$388.35	$299.10
52-Week Low	$269.75	$151.43
Typical Hold Time	20 Days	5 Days
Enterprise Value	$117.70B	$39.03B
Dividend Yield	1.27%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Stryker Corporation

Stryker (SYK) trades at $279.15, up 1.36% on the day, amid a mixed technical and fundamental backdrop. The stock shows bearish technical signals with key support at $268 and resistance at $284, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus of 71% buy ratings. Recent news highlights ongoing legal scrutiny over manufacturing issues, but the company maintains robust cash flow and earnings growth, with Q3 2026 results pending.

Outlook: SYK offers growth potential with a consensus price target of $368.11, supported by profitability and innovation, but faces near-term risks from legal investigations and technical weakness. Investors should weigh strong fundamentals against sentiment headwinds.

Veeva Systems

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SYK

1% Buy99% Sell

Avg holding period · 20 Days

VEEV

100% Buy0% Sell

Avg holding period · 5 Days

Top news

Latest headlines on both assets

SYK

Stryker faces investigation after CEO reveals ongoing manufacturing issues, stock drops nearly 9%.PRNewsWire · 1 day agoBearish Stryker stock drops 8.8% on unresolved manufacturing issues despite strong growth outlookDanny Green · 2 days agoNeutral Stryker upgraded to 'Strong Buy' after price drop to $275, showing strong growth and solid returns potential.Seeking Alpha · 4 days agoBullish View details →

VEEV

Biopharma leaders showcase AI and cloud tech to speed drug development at Veeva SummitPRNewsWire · 1 day agoBullish Over 175 biotechs adopt Veeva Basics to streamline drug development and regulatory processesPRNewsWire · 2 days agoBullish View details →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

About Veeva Systems

Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.